WealthShield Partners LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 14.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,000 shares of the healthcare conglomerate’s stock after purchasing an additional 646 shares during the quarter. WealthShield Partners LLC’s holdings in UnitedHealth Group were worth $2,525,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of UNH. TimeScale Financial Inc. raised its stake in shares of UnitedHealth Group by 276.9% in the third quarter. TimeScale Financial Inc. now owns 49 shares of the healthcare conglomerate’s stock valued at $25,000 after acquiring an additional 36 shares during the period. Pflug Koory LLC raised its stake in shares of UnitedHealth Group by 160.0% in the third quarter. Pflug Koory LLC now owns 52 shares of the healthcare conglomerate’s stock valued at $26,000 after acquiring an additional 32 shares during the period. Urban Wealth Management LLC bought a new position in shares of UnitedHealth Group in the second quarter worth about $29,000. Knott David M Jr bought a new position in shares of UnitedHealth Group in the second quarter worth about $29,000. Finally, Belmont Capital LLC grew its holdings in shares of UnitedHealth Group by 294.1% in the third quarter. Belmont Capital LLC now owns 67 shares of the healthcare conglomerate’s stock worth $34,000 after purchasing an additional 50 shares during the last quarter. Hedge funds and other institutional investors own 86.31% of the company’s stock.
Insider Activity at UnitedHealth Group
In related news, EVP Erin Mcsweeney sold 450 shares of UnitedHealth Group stock in a transaction on Wednesday, December 7th. The shares were sold at an average price of $542.30, for a total value of $244,035.00. Following the sale, the executive vice president now owns 8,736 shares of the company’s stock, valued at approximately $4,737,532.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.40% of the stock is owned by corporate insiders.
UnitedHealth Group Stock Performance
UnitedHealth Group (NYSE:UNH – Get Rating) last issued its quarterly earnings data on Friday, January 13th. The healthcare conglomerate reported $5.34 EPS for the quarter, topping analysts’ consensus estimates of $5.17 by $0.17. The business had revenue of $82.79 billion for the quarter, compared to analysts’ expectations of $82.53 billion. UnitedHealth Group had a net margin of 6.21% and a return on equity of 27.04%. The business’s revenue was up 12.3% on a year-over-year basis. During the same quarter last year, the company earned $4.48 EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 24.9 EPS for the current year.
UnitedHealth Group Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 13th. Investors of record on Monday, December 5th were paid a $1.65 dividend. The ex-dividend date was Friday, December 2nd. This represents a $6.60 dividend on an annualized basis and a yield of 1.34%. UnitedHealth Group’s dividend payout ratio is currently 31.15%.
Wall Street Analysts Forecast Growth
A number of research firms have recently commented on UNH. SVB Leerink cut their price target on shares of UnitedHealth Group from $625.00 to $618.00 and set an “outperform” rating on the stock in a report on Monday, October 17th. Credit Suisse Group increased their target price on shares of UnitedHealth Group from $590.00 to $610.00 and gave the stock an “outperform” rating in a report on Wednesday, December 7th. Royal Bank of Canada increased their target price on shares of UnitedHealth Group from $588.00 to $592.00 and gave the stock an “outperform” rating in a report on Monday, October 17th. Deutsche Bank Aktiengesellschaft increased their target price on shares of UnitedHealth Group from $615.00 to $617.00 and gave the stock a “buy” rating in a report on Tuesday. Finally, StockNews.com began coverage on shares of UnitedHealth Group in a report on Wednesday, October 12th. They set a “strong-buy” rating on the stock. Three investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $599.39.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.